ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,234Medicare Part D Prescriptions Filled, Including Refills

Rank: 129 out of 939

$853K Total Retail Price of All Prescriptions

Rank: 73 out of 939

1,155 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 1,155 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 1,155 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 6,391 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,016 328 S3 1 1
LISINOPRIL 558 205 2 3
FUROSEMIDE 491 310 3 7
SIMVASTATIN 483 256 4 2
AMLODIPINE BESYLATE 367 208 5 6
POTASSIUM CHLORIDE 349 205 6 9
LEVOTHYROXINE SODIUM 314 161 7 4
CARVEDILOL 308 159 8 25
METOPROLOL TARTRATE 308 140 8 10
METFORMIN HCL 298 129 10 8
GABAPENTIN 263 77 11 11
OMEPRAZOLE 242 117 12 5
NEXIUM 231 83 13 18
WARFARIN SODIUM 229 133 14 17
HYDROCHLOROTHIAZIDE 217 84 15 12
RANITIDINE HCL 199 105 16 35
PRAVASTATIN SODIUM 191 82 17 13
TRAMADOL HCL 188 67 18 16
ZOLPIDEM TARTRATE 182 95 19 20
CITALOPRAM HBR 182 80 19 15
MELOXICAM 150 68 21 14
ATORVASTATIN CALCIUM 142 64 22 22
CYCLOBENZAPRINE HCL 139 24 R 23 36
PROMETHAZINE HCL 134 33 R 24 68
TAMSULOSIN HCL 132 64 25 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 131 66 26 23
TRAZODONE HCL 126 38 27 26
PROAIR HFA 125 60 28 41
LYRICA 107 43 29 63
CLONIDINE HCL 105 39 30 39
CLOPIDOGREL 104 56 31 28
GLIMEPIRIDE 104 82 31 37
LOSARTAN POTASSIUM 101 71 33 29
KLOR-CON M20 100 72 34 90
ISOSORBIDE MONONITRATE ER 99 59 35 53
DIGOXIN 87 74 36 45
CYMBALTA 84 20 37 44
LANTUS SOLOSTAR 84 28 37 128
NAPROXEN 83 23 39 72
SPIRIVA 81 55 40 73
PLAVIX 79 50 41 48
DIOVAN 76 40 42 50
QUETIAPINE FUMARATE 75 42 43 69
CARISOPRODOL 74 0 R 44 51
SINGULAIR 69 24 45 101
PEN NEEDLE 68 36 46 193
PANTOPRAZOLE SODIUM 67 43 47 66
PHENYTOIN SODIUM EXTENDED 67 18 47 99
PREDNISONE 67 16 47 42
VENTOLIN HFA 66 17 50 80
ADVAIR DISKUS 66 34 50 60
ALENDRONATE SODIUM 62 37 52 40
ALLOPURINOL 60 30 53 31
AZITHROMYCIN 59 21 54 32
ROPINIROLE HCL 58 29 55 78
NOVOLOG FLEXPEN 57 22 56 295
SERTRALINE HCL 57 24 56 24
ESCITALOPRAM OXALATE 55 11 58 61
LOVASTATIN 53 36 59 46
MONTELUKAST SODIUM 52 21 60 172
QUINAPRIL HCL 51 34 61 133
METOPROLOL SUCCINATE 50 24 62 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.